About Mytide Therapeutics
Mytide Therapeutics is a private company based in Boston, Massachusetts. It has reported $8,231,824 raised in two offerings on Form D since January 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 2022 | Jan 6, 2023 | $1,164,111of $2.5M target | 9 | $129K | Equity, Series A-3 Preferred StockRule 506(b) | Form D ↗ |
| Dec 30, 2021 | Jan 21, 2022amended Jun 7, 2022 | $7,067,713fully sold | 23 | $307K | Equity, Series A Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $8,231,824 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mytide Therapeutics's Form D filed Jan 6, 2023.
EA
Errik Anderson
Director
JN
Jason Norris
Executive officer, director and promoter
DT
Dale Thomas
Executive officer, director and promoter